Complimentary Science and Innovation Forum to Focus on Emerging SCD Therapies

AABB and QuidelOrtho are pleased to welcome Titilope Fasipe, MD, PhD, for a Science and Innovation Forum focused on emerging therapies for sickle cell disease (SCD) as part of AABB’s National Sickle Cell Awareness Month activities.

Fasipe is the co-director of the Sickle Cell and Thalassemia Program at Texas Children’s Cancer and Hematology Center and an assistant professor in the Department of Pediatrics at Baylor College of Medicine/Texas Children’s Hospital.

In this complimentary program, Fasipe will discuss her lived experiences as a sickle cell warrior and the challenges associated with treating patients with SCD. She will also focus on the research landscape of emerging therapies for SCD, including promising gene and cellular therapies.

The program will take place 2-3 p.m. ET on Friday, Sept. 22. Registration is complimentary but required to attend.